Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Nov 9 - Nov 14
Drugs such as Ozempic and Wegovy reduce the risk of the tissue damage that affects up to half of the 100,000 people a year in the UK who suffer a heart attack, according to the study
Some people get side effects, especially at the start
What health professionals do with the person in front of them who's at high risk already, who has cardiovascular disease, or whose overweight is contributing to their risk. It's timely, because we've got GLP-1 therapies available for the first time, which not only help people control their weight, but also have consequences in terms of reducing cardiovascular events and improving outcomes. Australia leading the world in GLP-1 guidance Prof
doi: 10.1038/ijo.2013.149 62 BlundellJFinlaysonGAxelsenMFlintAGibbonsCKvistTet al
US$ 22.88
US$ 19.99
US$ 22.79
US$ 26.45
US$ 29.19
US$ 27.02
